Vaccination safety update;Impfsicherheit heute

Deutsches Arzteblatt

Volumn 105, Issue 34-35, 2008, Pages 590-595

  Schneeweiß, Burkhard ^a,c   Pfleiderer, Michael ^b   Keller Stanislawski, Brigitte ^b  

^a Arzneimittelkommission der deutschen Arzteschaft   (Germany)

^b PAUL EHRLICH INSTITUT   (Germany)

^c NONE   (Germany)

Author keywords

Safety; Side effects; Surveillance; Unjustified scepticism about vaccines; Vaccination

Indexed keywords

ACELLULAR VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; VACCINE;

ALLERGY; AUTISM; AUTOIMMUNE DISEASE; CLINICAL TRIAL; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; DRUG WITHDRAWAL; ENCEPHALITIS; EPIDEMIC ENCEPHALITIS; EPILEPSY; FEBRILE CONVULSION; FEVER; GERMANY; HEALTH SURVEY; HEPATITIS B; HUMAN; IMMUNE SYSTEM; IMMUNOGENICITY; INFLUENZA VACCINATION; INFORMATION RETRIEVAL; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE RHEUMATOID ARTHRITIS; LICENSING; MULTIPLE SCLEROSIS; REVIEW; RISK ASSESSMENT; SUDDEN INFANT DEATH SYNDROME; TICK BORNE ENCEPHALITIS; UNSPECIFIED SIDE EFFECT; VACCINATION;

EID: 54249093295     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2008.0590     Document Type: Review

References (25)

1. Ständige Impfkommission STIKO: Aktualisierte Hinweise für Ärzte zum Aufklärungsbedarf über mögliche unerwünschte Wirkungen bei Schutzimpfungen. Epidemiol Bull 2007; 25.
2. Stajich GV, Lopez GJ, Harry WW, Sexson WR: Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants. J Pediatr 2000; 136: 679-81.
3. The European Agency for the Evaluation of Medicinal Products - Evaluation of Medicines for Human Use. CPMP position paper on thiomersal - implementation of the warning statement relating to sensitisation. CPMP/2612/99. www.eudra.org/emea.html
4. Hernán MA, Jick SS, Olek MJ, Jick H: Recombinant hepatitis B vaccine and the risk of multiple sclerosis. Neurology 2005; 63: 838-42.
5. DeStefano F, Weintraub ES, Chen RT: Determining risk of multiple sclerosis after hepatitis B vaccine: time since vaccination and source of data. Pharmacoepidemiol Drug Saf 2004; 13:143.
6. WHO Global Advisory Committee on Vaccine Safety: Response to the paper by MA Hernán and others in Neurology 14 Sept 2004. www.who.int/ vaccine_safety/topics/hepatitisb/multiple_sclerosis/sep_04/en/
7. Wakefield AJ: Autism, inflammatory bowel disease, and MMR vaccine. Lancet 1998; 351: 1356.
8. Board on population health and public health practice. Immunization safety review: Vaccines and autism. Institute of Medicine of the National Academies, www.iom.edu
9. Classen JB, Classen DC: Association between type 1 diabetes and Hib vaccine. Brit Med J 1999; 319: 1133.
10. Otten A, Helmke K, Stief T, Mueller-Eckhard G, Willems WR, Federlin K: Mumps, mumps vaccination, islet cell antibodies and the first manifestation of Diabetes mellitus type I. Behring Inst Mitt 1984; 7: 83-8.
11. ACIP: Recommendations of the Immunization Practices Advisory Committee: Mumps prevention. Am J Dis Child 1989; 143: 1141-2.
12. von Kries R, Schmitt HJ: Diabetes mellitus nach Hib-Impfung? Kinderärztl Praxis 1999; 8: 589-90.
13. Buchwald G: Impfen - Das Geschäft mit der Angst. Verlag Knaur 1997.
14. Paul Ehrlich-Institut. www.pei.de/cln_046/nn_163090/DE/ infos/patienten/am-sik-pat/am-bse/am-bse-node.html?_nnn=true
15. Fiddike M: Praxisinformationen - Kritische Betrachtung der Impffrage. www.dr-marc-fiddike.de
16. Baenkler H-W: Faszination Immunologie. Stuttgart: Hippokrates Verlag 1992.
17. Mutius E von, Fritzsch C, Weiland SK, Roell G, Magnussen H: Prevalence of asthma and allergic disorders among children in united Germany: a descriptive comparison. BMJ 1992; 305: 1395-9.
18. Ehrengut W: Die Pertussis-Impfenzephalopathie, eine Legende? Der Kinderarzt 1992; 23: 222.
19. Pollock T, Miller E, Mortimer J: Symptoms after primary immunization with DTP and DT vaccine. Lancet 1995; 274: 1518-28.
20. Ray P, Hayward J, Michelson D et al.: Encephalopathy after whole-cell pertussis or measles vaccination: lack of evidence for a causal association in a retrospective study. Pediatr Infect Dis J 2006; 25: 768-73.
21. Stehr K, Heininger U, Beer E, Wenzel D: Rehabilitation der Pertussisimpfung - postvakzinale Dauerschäden: ein Mythos! Pädiatr Praxis 1994; 47: 175-83.
22. Barlow WE, Davis RL, Glasser JW et al.: Center for Health Studies, Group Health cooperation, Seattle. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med 2001; 345: 656-61.
23. von Kries R, Toschke AM, Strassburger K et al.: Sudden and unexspected deaths after the administration of hexavalent vaccines (diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, haemophilus influenzae type b): is there a signal? Eur J Pediatr 2005; 164: 61.
24. Vennemann MMT, Butterfaß-Bahloul T, Jorch G et al.: Sudden infant death syndrome: No increased risk after immunisation. Vaccine 2007; 25: 336-40.
25. Vennemann MMT, Höffgen M, Bajanowski T, Hense HW, Mitchell EA: Do immunizations reduce the risk for SIDS? A meta-analysis. Vaccine 2007; 25: 4875-9.